fenofibric acid 45 MG Delayed Release Oral Capsule [Trilipix]
RxNorm concept 828381, branded drug (sbd). Prescribable name: Trilipix 45 MG Delayed Release Oral Capsule.
- RxCUI
- 828381
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/828381 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Trilipix 45 MG (as choline fenofibrate) Delayed Release Oral Capsule; Trilipix 45 MG Delayed Release Oral Capsule
Related concepts
- fenofibric acid 45 MG (SCDC, consists of)
- fenofibric acid 45 MG [Trilipix] (SBDC, consists of)
- Delayed Release Oral Capsule (DF, has dose form)
- Trilipix (BN, has ingredient)
- fenofibric acid 45 MG Delayed Release Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 00074316190
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 828381 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/828381 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 828381. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.